United Therapeutics
Trade United Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About UTHR
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.
UTHR Key Statistics
Stock Snapshot
As of today, United Therapeutics(UTHR) shares are valued at $503.69. The company's market cap stands at 21.68B, with a P/E ratio of 19.05.
On 2026-01-07, United Therapeutics(UTHR) stock moved within a range of $501.08 to $509.40. With shares now at $503.69, the stock is trading +0.5% above its intraday low and -1.1% below the session's peak.
Trading volume for United Therapeutics(UTHR) stock has reached 301.59K, versus its average volume of 335.97K.
Over the past 52 weeks, United Therapeutics(UTHR) stock has traded between a high of $519.99 and a low of $266.98.
Over the past 52 weeks, United Therapeutics(UTHR) stock has traded between a high of $519.99 and a low of $266.98.
UTHR News
UBS raised the firm’s price target on United Therapeutics (UTHR) to $645 from $600 and keeps a Buy rating on the shares. The Biotech sector enters 2026 on a cau...